BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Fundamental Analysis & Valuation

FRA:BRYN • US0846707026

424.95 EUR
-4.1 (-0.96%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This BRYN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

BRYN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Financial Services industry. BRYN has only an average score on both its financial health and profitability. BRYN is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, BRYN could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. BRYN.DE Profitability Analysis

1.1 Basic Checks

  • In the past year BRYN was profitable.
  • In the past year BRYN had a positive cash flow from operations.
  • Of the past 5 years BRYN 4 years were profitable.
  • In the past 5 years BRYN always reported a positive cash flow from operatings.
BRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B 80B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.50%, BRYN is in the better half of the industry, outperforming 78.18% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 9.66%, BRYN is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
  • BRYN has a better Return On Invested Capital (4.53%) than 61.82% of its industry peers.
  • BRYN had an Average Return On Invested Capital over the past 3 years of 4.13%. This is below the industry average of 8.26%.
  • The 3 year average ROIC (4.13%) for BRYN is below the current ROIC(4.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.5%
ROE 9.66%
ROIC 4.53%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
BRYN.DE Yearly ROA, ROE, ROICBRYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • BRYN has a Profit Margin of 18.13%. This is in the better half of the industry: BRYN outperforms 72.73% of its industry peers.
  • BRYN's Profit Margin has declined in the last couple of years.
  • BRYN has a Operating Margin of 16.72%. This is comparable to the rest of the industry: BRYN outperforms 56.36% of its industry peers.
  • BRYN's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 17.71%, BRYN is doing worse than 61.82% of the companies in the same industry.
  • BRYN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.72%
PM (TTM) 18.13%
GM 17.71%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
BRYN.DE Yearly Profit, Operating, Gross MarginsBRYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BRYN.DE Health Analysis

2.1 Basic Checks

  • BRYN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for BRYN has been reduced compared to 1 year ago.
  • The number of shares outstanding for BRYN has been reduced compared to 5 years ago.
  • The debt/assets ratio for BRYN has been reduced compared to a year ago.
BRYN.DE Yearly Shares OutstandingBRYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
BRYN.DE Yearly Total Debt VS Total AssetsBRYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

  • BRYN has an Altman-Z score of 1.36. This is a bad value and indicates that BRYN is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of BRYN (1.36) is comparable to the rest of the industry.
  • The Debt to FCF ratio of BRYN is 6.58, which is on the high side as it means it would take BRYN, 6.58 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BRYN (6.58) is better than 63.64% of its industry peers.
  • A Debt/Equity ratio of 0.18 indicates that BRYN is not too dependend on debt financing.
  • BRYN has a better Debt to Equity ratio (0.18) than 67.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 6.58
Altman-Z 1.36
ROIC/WACC1.41
WACC3.22%
BRYN.DE Yearly LT Debt VS Equity VS FCFBRYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.3 Liquidity

  • BRYN has a Current Ratio of 1.33. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.33, BRYN perfoms like the industry average, outperforming 50.91% of the companies in the same industry.
  • BRYN has a Quick Ratio of 1.11. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
  • BRYN has a Quick ratio (1.11) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.11
BRYN.DE Yearly Current Assets VS Current LiabilitesBRYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BRYN.DE Growth Analysis

3.1 Past

  • BRYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.97%, which is quite good.
  • The Earnings Per Share has been growing by 17.78% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 0.60% in the past year.
  • BRYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.84% yearly.
EPS 1Y (TTM)17.97%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%33.51%
Revenue 1Y (TTM)0.6%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%2.13%

3.2 Future

  • Based on estimates for the next years, BRYN will show a small growth in Earnings Per Share. The EPS will grow by 2.26% on average per year.
  • Based on estimates for the next years, BRYN will show a small growth in Revenue. The Revenue will grow by 4.89% on average per year.
EPS Next Y-0.33%
EPS Next 2Y0.31%
EPS Next 3Y1.09%
EPS Next 5Y2.26%
Revenue Next Year0.8%
Revenue Next 2Y0.19%
Revenue Next 3Y1.32%
Revenue Next 5Y4.89%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRYN.DE Yearly Revenue VS EstimatesBRYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100B 200B 300B 400B
BRYN.DE Yearly EPS VS EstimatesBRYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10K 20K 30K

More info and screens

Find the best growth stocksShow best growing peers

8

4. BRYN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • BRYN is valuated cheaply with a Price/Earnings ratio of 0.01.
  • Based on the Price/Earnings ratio, BRYN is valued cheaply inside the industry as 98.18% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.29. BRYN is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 0.01, the valuation of BRYN can be described as very cheap.
  • BRYN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRYN is cheaper than 98.18% of the companies in the same industry.
  • BRYN is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.01
Fwd PE 0.01
BRYN.DE Price Earnings VS Forward Price EarningsBRYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • BRYN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRYN is cheaper than 90.91% of the companies in the same industry.
  • 98.18% of the companies in the same industry are more expensive than BRYN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.04
EV/EBITDA 0.64
BRYN.DE Per share dataBRYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100K 200K 300K 400K

4.3 Compensation for Growth

  • The decent profitability rating of BRYN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2Y0.31%
EPS Next 3Y1.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BRYN.DE Dividend Analysis

5.1 Amount

  • No dividends for BRYN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BRYN.DE Fundamentals: All Metrics, Ratios and Statistics

BERKSHIRE HATHAWAY INC-CL B

FRA:BRYN (3/6/2026, 7:00:00 PM)

424.95

-4.1 (-0.96%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-28
Earnings (Next)05-01
Inst Owners26.93%
Inst Owner ChangeN/A
Ins Owners37.74%
Ins Owner ChangeN/A
Market Cap611.93M
Revenue(TTM)372.13B
Net Income(TTM)67.46B
Analysts44
Price Target442.96 (4.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.5%
Min EPS beat(2)0.19%
Max EPS beat(2)4.81%
EPS beat(4)3
Avg EPS beat(4)9.5%
Min EPS beat(4)-9.78%
Max EPS beat(4)42.8%
EPS beat(8)6
Avg EPS beat(8)8.01%
EPS beat(12)8
Avg EPS beat(12)5.87%
EPS beat(16)12
Avg EPS beat(16)8.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)0.72%
Revenue beat(4)1
Avg Revenue beat(4)-1.43%
Min Revenue beat(4)-4.09%
Max Revenue beat(4)0.72%
Revenue beat(8)3
Avg Revenue beat(8)-1.35%
Revenue beat(12)5
Avg Revenue beat(12)-0.47%
Revenue beat(16)6
Avg Revenue beat(16)-0.84%
PT rev (1m)-1.09%
PT rev (3m)-1.77%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-4.66%
EPS NY rev (1m)0%
EPS NY rev (3m)2.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 0.01
Fwd PE 0.01
P/S 0
P/FCF 0.04
P/OCF 0.02
P/B 0
P/tB 0
EV/EBITDA 0.64
EPS(TTM)29214.33
EY6874.77%
EPS(NY)28574.65
Fwd EY6724.24%
FCF(TTM)11551.8
FCFY2718.39%
OCF(TTM)23549.4
OCFY5541.69%
SpS222432.62
BVpS417309.23
TBVpS345795
PEG (NY)N/A
PEG (5Y)0
Graham Number523743
Profitability
Industry RankSector Rank
ROA 5.5%
ROE 9.66%
ROCE 5.61%
ROIC 4.53%
ROICexc 4.87%
ROICexgc 5.82%
OM 16.72%
PM (TTM) 18.13%
GM 17.71%
FCFM 5.19%
ROA(3y)4.77%
ROA(5y)5.71%
ROE(3y)8.68%
ROE(5y)10.68%
ROIC(3y)4.13%
ROIC(5y)3.72%
ROICexc(3y)4.31%
ROICexc(5y)3.94%
ROICexgc(3y)5.19%
ROICexgc(5y)4.78%
ROCE(3y)5.11%
ROCE(5y)4.61%
ROICexgc growth 3Y9.15%
ROICexgc growth 5Y4.04%
ROICexc growth 3Y9.9%
ROICexc growth 5Y4.98%
OM growth 3Y7.37%
OM growth 5Y4.91%
PM growth 3Y-9.72%
PM growth 5Y-5.61%
GM growth 3Y3.45%
GM growth 5Y2.09%
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 6.58
Debt/EBITDA 1.69
Cap/Depr 151.95%
Cap/Sales 5.39%
Interest Coverage 12.22
Cash Conversion 52.22%
Profit Quality 28.65%
Current Ratio 1.33
Quick Ratio 1.11
Altman-Z 1.36
F-Score4
WACC3.22%
ROIC/WACC1.41
Cap/Depr(3y)148.32%
Cap/Depr(5y)138.32%
Cap/Sales(3y)5.18%
Cap/Sales(5y)5.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.97%
EPS 3Y21.97%
EPS 5Y17.78%
EPS Q2Q%33.51%
EPS Next Y-0.33%
EPS Next 2Y0.31%
EPS Next 3Y1.09%
EPS Next 5Y2.26%
Revenue 1Y (TTM)0.6%
Revenue growth 3Y10.38%
Revenue growth 5Y7.84%
Sales Q2Q%2.13%
Revenue Next Year0.8%
Revenue Next 2Y0.19%
Revenue Next 3Y1.32%
Revenue Next 5Y4.89%
EBIT growth 1Y15.71%
EBIT growth 3Y18.52%
EBIT growth 5Y13.14%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.02%
FCF growth 3Y-23.7%
FCF growth 5Y-12.55%
OCF growth 1Y-12.66%
OCF growth 3Y-8.11%
OCF growth 5Y-4.59%

BERKSHIRE HATHAWAY INC-CL B / BRYN.DE FAQ

Can you provide the ChartMill fundamental rating for BERKSHIRE HATHAWAY INC-CL B?

ChartMill assigns a fundamental rating of 5 / 10 to BRYN.DE.


What is the valuation status of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

ChartMill assigns a valuation rating of 8 / 10 to BERKSHIRE HATHAWAY INC-CL B (BRYN.DE). This can be considered as Undervalued.


What is the profitability of BRYN stock?

BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) has a profitability rating of 6 / 10.


What are the PE and PB ratios of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

The Price/Earnings (PE) ratio for BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is 0.01 and the Price/Book (PB) ratio is 0.


How financially healthy is BERKSHIRE HATHAWAY INC-CL B?

The financial health rating of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is 5 / 10.